Evidence map›Paper›PMID 41683856›Full record

ArticleInternational journal of molecular sciences2026

Conserved Enzymatic Peptides in

Kemily Stephanie de Godoi, Fernanda Calheta Vieira Portaro, Patrick Jack Spencer, Hugo Vigerelli, Wilmar Dias da Silva

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kemily Stephanie de GodoiImmunochemistry Laboratory, Instituto Butantan, São Paulo 05503-900, Brazil.ORCID 0000-0002-1775-0540
Fernanda Calheta Vieira PortaroLaboratory of Structure and Function of Biomolecules, Instituto Butantan, São Paulo 05503-900, Brazil.ORCID 0000-0002-9582-4699
Patrick Jack SpencerBiotechnology Center, Nuclear and Energy Research Institute (IPEN), São Paulo 05508-900, Brazil.ORCID 0000-0001-8949-7735
Hugo VigerelliCentre of Excellence in New Target Discovery (CENTD), Instituto Butantan, São Paulo 05503-900, Brazil.ORCID 0000-0002-8197-2260
Wilmar Dias da SilvaImmunochemistry Laboratory, Instituto Butantan, São Paulo 05503-900, Brazil.

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/07467-1GlaxoSmithKline (Brazil) 2015/50040-4GlaxoSmithKline (Brazil) 2020/13139-0
6 · The paper itself

Abstract

Snakebite envenoming remains a critical public health issue, and the molecular variability of venoms limits the cross-species efficacy of conventional antivenoms. Here, we conducted a comparative proteomic analysis of

Indexed as

BitisPeptidesProteomicsViper VenomsAmino Acid SequenceAnimalsAntiveninsConserved SequenceCross ReactionsMetalloproteasesPhospholipases A2Serine ProteasesTandem Mass SpectrometryVenomous SnakesViperinaeAntiveninsMetalloproteasesPeptidesPhospholipases A2Serine ProteasesViper Venomscomparative proteomicscomplementary therapycross-reactive antitoxinssnake envenomationsnake venom proteasesViperidae venoms

Identifiers

PMID41683856
PMCPMC12898025

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.